Seeking Alpha

In addition to rumors of Dendreon (DNDN +5%) looking to sell itself, the stock also appears to...

In addition to rumors of Dendreon (DNDN +5%) looking to sell itself, the stock also appears to be reacting to Provenge's recent inclusion on the European Medicines Agencies XEVMPD, a medicinal products dictionary that outlines a drug's basic product details. Submission of product data to the XEVMPD is now mandatory for all drugs registered in the European Union.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs